|
MAGED1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.556700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.25197638314967E-12 |
| Normal-vs-Stage2 |
3.63749999999774E-05 |
| Normal-vs-Stage3 |
8.371000E-01 |
| Normal-vs-Stage4 |
6.827000E-01 |
| Stage1-vs-Stage2 |
7.865800E-01 |
| Stage1-vs-Stage3 |
3.048600E-01 |
| Stage1-vs-Stage4 |
1.578390E-02 |
| Stage2-vs-Stage3 |
2.879400E-01 |
| Stage2-vs-Stage4 |
2.494400E-02 |
| Stage3-vs-Stage4 |
9.795200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.837400E-03 |
| Normal-vs-AfricanAmerican |
6.583400E-04 |
| Normal-vs-Asian |
2.506000E-02 |
| Caucasian-vs-AfricanAmerican |
6.762400E-01 |
| Caucasian-vs-Asian |
8.590800E-01 |
| AfricanAmerican-vs-Asian |
9.370800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.608300E-02 |
| Normal-vs-Female |
5.386800E-04 |
| Male-vs-Female |
8.417000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.565800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.874400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.09649999477679E-08 |
| Normal-vs-Age(81-100Yrs) |
5.792400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.675200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.065600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.960400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.781400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.143020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.509200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.789400E-04 |
| Normal-vs-Grade 2 |
1.39122047215778E-12 |
| Normal-vs-Grade 3 |
3.436800E-01 |
| Normal-vs-Grade 4 |
7.483600E-01 |
| Grade 1-vs-Grade 2 |
7.877800E-01 |
| Grade 1-vs-Grade 3 |
4.298600E-01 |
| Grade 1-vs-Grade 4 |
9.294200E-02 |
| Grade 2-vs-Grade 3 |
2.708000E-01 |
| Grade 2-vs-Grade 4 |
2.119800E-02 |
| Grade 3-vs-Grade 4 |
5.693600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
8.396600E-01 |
| ccA subtype-vs-ccB subtype |
1.254120E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.461800E-01 |
| Normal-vs-N1 |
9.216400E-01 |
| N0-vs-N1 |
5.629600E-01 |
|
|
